Blais Lucie, Vilain Anne, Kettani Fatima-Zohra, Forget Amélie, Lalonde Geneviève, Beauchesne Marie-France, Ducharme Francine M, Lemière Catherine
Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada Hôpital du Sacré-Cœur de Montréal, Montréal, Québec, Canada Endowment Pharmaceutical Chair AstraZeneca in Respiratory Health, Montréal, Québec, Canada.
Faculté de Pharmacie, Université de Montréal, Montréal, Québec, Canada.
BMJ Open. 2014 Nov 28;4(11):e005903. doi: 10.1136/bmjopen-2014-005903.
Adherence to inhaled corticosteroids (ICS) is a major issue in asthma. This study aimed to estimate the accuracy of the days' supply and number of refills allowed, variables recorded in Québec claims databases and used to estimate adherence, and to develop correction factors, if required. We hypothesised that the accuracy of the days' supply for ICS would be low whereas the accuracy of the number of refills allowed would be high.
40 community pharmacies in Québec (Canada) and a medication registry.
We collected data for 1108 ICS original prescriptions stored in the 40 pharmacies (sample 1), and we obtained a second sample of 2676 ICS prescriptions selected from reMed, a medication registry (sample 2).
We estimated the concordance of the days' supply and number of refills between Québec claims databases and the original prescription from sample 1. We developed a correction factor for the days' supply in sample 1 and validated it in sample 2. Analyses were stratified by age: 0-11 and 12-64 years.
In sample 1, the concordance for the days' supply was 39.6% (95% CI 37.6% to 41.6%) in those aged 0-11 years and 56% (54.9% to 57.2%) in those aged 12-64 years. The concordance increased to 59.4% (58.2% to 60.5%) in those aged 0-11 years and 74.2% (73.5% to 74.9%) in those aged 12-64 years after applying the correction factors in sample 2. The concordance for the refills allowed was 92.1% (91% to 93.1%) in those aged 0-11 years and 93.1% (92.5% to 93.7%) in those aged 12-64 years in sample 1.
The accuracy of the days' supply was moderate among those aged 0-11 years and substantial among those aged 12-64 years after applying the correction factors. The accuracy of the number of refills was almost perfect in both groups.
吸入性糖皮质激素(ICS)的依从性是哮喘治疗中的一个主要问题。本研究旨在评估魁北克省医保理赔数据库中记录的、用于评估依从性的每日用药量供应天数及允许的再填充次数这两个变量的准确性,并在必要时制定校正因子。我们假设ICS每日用药量供应天数的准确性较低,而允许的再填充次数的准确性较高。
加拿大魁北克省的40家社区药房及一个药物登记处。
我们收集了存储在40家药房中的1108份ICS原始处方的数据(样本1),并从一个药物登记处reMed中选取了2676份ICS处方作为第二个样本(样本2)。
我们评估了魁北克省医保理赔数据库与样本1中的原始处方之间每日用药量供应天数及再填充次数的一致性。我们为样本1中的每日用药量供应天数制定了一个校正因子,并在样本2中进行了验证。分析按年龄分层:0至11岁和12至64岁。
在样本1中,0至11岁人群每日用药量供应天数的一致性为39.6%(95%CI 37.6%至41.6%),12至64岁人群为56%(54.9%至57.2%)。在样本2中应用校正因子后,0至11岁人群的一致性提高到59.4%(58.2%至60.5%),12至64岁人群为74.2%(73.5%至74.9%)。在样本1中,0至11岁人群允许的再填充次数的一致性为92.1%(91%至93.1%),12至64岁人群为93.1%(92.5%至93.7%)。
应用校正因子后,0至11岁人群每日用药量供应天数的准确性中等,12至64岁人群较高。两组中允许的再填充次数的准确性几乎完美。